Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.

Hepatic encephalopathy (HE) represents a dysfunctional gut-liver-brain axis in cirrhosis which can negatively impact outcomes. This altered gut-brain relationship has been treated using gut-selective antibiotics such as rifaximin, that improve cognitive function in HE, especially its subclinical for...

Full description

Bibliographic Details
Main Authors: Jasmohan S Bajaj, Douglas M Heuman, Arun J Sanyal, Phillip B Hylemon, Richard K Sterling, R Todd Stravitz, Michael Fuchs, Jason M Ridlon, Kalyani Daita, Pamela Monteith, Nicole A Noble, Melanie B White, Andmorgan Fisher, Masoumeh Sikaroodi, Huzefa Rangwala, Patrick M Gillevet
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3615021?pdf=render

Internet

http://europepmc.org/articles/PMC3615021?pdf=render

Similar Items